Murj®, a US-based cardiac device management software company, has announced its official expansion into the Australi...
Insilico Medicine, a Hong Kong-based clinical-stage generative artificial intelligence (AI)-driven drug discovery compan...
Japan-based Shimadzu Corporation has released the PPSQ-51A/53A SPD-40 model protein sequencers. These instruments c...
MediThinQ, a South Korea-based innovator in surgical visualisation technologies, has entered into an exclusive multi-yea...
Qiagen has announced that its QIAstat-Dx Meningitis/Encephalitis (ME) Panel has been included in the Australian Register...
Japan-based startup Axcelead Drug Discovery Partners (DDP), Inc. has entered a collaboration with Lilly TuneLab, a colla...
South Korea-based LG AI Research has signed a master agreement with D&D Pharmatech for a joint next-generation oral ...
Japan-based Fujifilm Corporation and Horiba have announced the co-development of a high-sensitivity inline Raman measure...
StemSight, a Finnish biotechnology startup developing off-the-shelf regenerative cell therapies for curing blindness, ha...
Germany-based ZEISS Medical Technology held a signing ceremony with the Aier Eye Hospital Group, China, entering into a ...
Japanese pharma firm Eisai Co. has announced a strategic investment supported by the UK Government under the Life Scienc...
South Korea-based startup AIRS Medical has announced a strategic growth investment from TA Associates, a leading global ...
Johnson & Johnson has announced an investment of more than $1 billion in Jacksonville, Florida to strengthen its Vis...
Nirrin Technologies, a developer of analytical tools designed to transform bioprocessing workflows, has announced the ap...
Qiagen N.V. has announced new additions to its QIAcuity digital PCR (dPCR) ecosystem, with a focus on expanding gene exp...
South Korea-based OliX Pharmaceuticals, a leading developer of RNAi therapeutics, has raised approximately KRW 110 ...
China-based Simcere Pharmaceutical Group has entered into a research collaboration agreement with Stanford Medicine, US ...
Japan's Lotte Holdings has announced an investment in ClearideBio Therapeutics AG, an early-stage biotechnology sta...
Taiwan-based Formosa Pharmaceuticals has entered into an exclusive licensing agreement with South Korea's Samil Pharmace...
Korea-based Dong-A ST has entered into an exclusive licensing agreement with Melbourne-based Arrotex Pharmaceuticals, fo...
PharmaEssentia USA Corporation, a subsidiary of PharmaEssentia Corporation, a global biopharmaceutical innovator based i...
China-based QingSong Health Corp and Basel Medical Group have announced the signing of a Memorandum of Strateg...
South Korea-based SK bioscience, a global innovative vaccine and biotech company, has announced that, after entering int...
Japan-based GNI Group Co. has entered into an agreement to acquire 100% of the shares of Ayumi Pharmaceutical Holdings C...
China-based Everest Medicines has entered into an exclusive licensing agreement with Jiangsu Vcare PharmaTech Co., ...
